Cargando…
The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK
BACKGROUND: Real-world prescription pathways leading to triple therapy (TT) (inhaled corticosteroid [ICS] plus long-acting β(2)-agonist bronchodilator [LABA] plus long-acting muscarinic antagonist) differ from Global initiative for chronic Obstructive Lung Disease [GOLD] and National Institute for H...
Autores principales: | Brusselle, Guy, Price, David, Gruffydd-Jones, Kevin, Miravitlles, Marc, Keininger, Dorothy L, Stewart, Rebecca, Baldwin, Michael, Jones, Rupert C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621207/ https://www.ncbi.nlm.nih.gov/pubmed/26527869 http://dx.doi.org/10.2147/COPD.S91694 |
Ejemplares similares
-
Changes in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care: a real-world study
por: Gruffydd-Jones, Kevin, et al.
Publicado: (2016) -
Erratum: Changes in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care: a real-world study
por: Gruffydd-Jones, Kevin, et al.
Publicado: (2017) -
Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns
por: Price, David, et al.
Publicado: (2014) -
Symptoms and impact of COPD assessed by an electronic diary in patients with moderate-to-severe COPD: psychometric results from the SHINE study
por: Kulich, Károly, et al.
Publicado: (2015) -
Mortality in COPD: Inevitable or Preventable? Insights from the Cardiovascular Arena
por: Halpin, David
Publicado: (2008)